In VitroModulation of the Multiple Sclerosis (MS)-Associated Retrovirus by Cytokines: Implications for MS Pathogenesis

References

• Baranzini SE, Elfstrom C, Chang SY, Butunoi C, Murray R, Higuchi R, Oksenberg JR (2000). Transcriptional analy-sis of multiple sclerosis brain lesions reveals a complex pattern of cytokine expression. J Immunol 165: 6576–6582.
   Google Scholar
• Biolchini A, Curreli S, Ziccheddu M, Serra C, Dolei A (2000). Opposite effects of interferony on CCR5 and CXCR4 expression and on entry of M- and T-tropic HIV in epithelial cells. AIDS 14: 7–9.
   Google Scholar
• Byrnes AA, McArthur JC, Karp CL (2002). Interferon-beta therapy for multiple sclerosis induces reciprocal changes in interleukin-12 and interleukin-10 produc-tion. Ann Neurol 51: 165–174.
   Google Scholar
• Conaldi PG, Bottelli A, Wade-Evans A, Biancone L, Baj A, Cantaluppi V, Serra C, Dolei A, Toniolo A, Camussi G (2000). HIV-1 persistent infection and cytokine in-duction in mesangial cells: a potential mechanism for HIV-associated glomerulosclerosis. AIDS 14: 2045–2047.
   Google Scholar
• Depil S, Roche C, Dussart P, Prin L (2002). Expression of a human endogenous retrovirus, HERV-K, in the blood cells of leukemia patients. no significant varia-tion of HERV-K expression in normal PBMCs after ex-posure to different factors (PHA, gamma irradiation, 5-azacytidine) that potentially modulate HERV expres-sion. Leukemia 16: 254–259.
   Google Scholar
• Dolei A, Arca MV, Tilocca F, Pietravalle M, Alemanno L, Toniolo A, Ameglio F (1994). Mutual interactions of HIV-1 and cytokines in adherent cells during acute in-fection. Arch Viro1134: 157–168.
   Google Scholar
• Dolei A, Biolchini A, Serra C, Curreli S, Gomes E, Dianzani F (1998). Increased replication of T-cell-tropic HIV strains and CXC-chemokine receptor-4 induction in T cells treated with macrophage inflammatory protein (MIP)-1a, MIP-1/3 and RANTES /3-chemokines. AIDS 12: 183–190.
   Google Scholar
• Dolei A, Serra C, Mameli G, Pugliatti M, Sechi S, Cirotto MC, Rosati G, Sotgiu S (2002). Multiple sclerosis-associated retrovirus (MSRV) in Sardinian MS patients. Neurology 58: 471–473.
   Google Scholar
• Duddy ME, Armstrong MA, Crockard AD, Hawkins SA (1999). Changes in plasma cytokines induced by interferon-/31a treatment in patients with multiple scle-rosis. J Neuroimmunol 101: 98–109.
   Google Scholar
• Durelli L, Verdun E, Barbero P, Bergui M, Versino E, Ghezzi A, Montanan i E, Zaffaroni M (2002). Every-other-day in-terferon beta-lb versus once-weekly interferon beta-1a for multiple sclerosis: results of a 2-year prospective randomised multicentre study (INCOMIN). Lancet 359: 1453–1460.
   Google Scholar
• Fauci AS (1996). Host factors and the pathogenesis of HIV-induced disease. Nature 384: 529–534.
   Google Scholar
• Garson J, Tuke PW, Giraud P, Paranhos-Baccala G, Perron H (1998). Detection of virion-associated MSRV-RNA in serum of patients with multiple sclerosis. Lancet 351: 33.
   Google Scholar
• Gonzalez-Scarano F, Rima B (1999). Infectious aetiology in multiple sclerosis: the debate continues. Trends Micro-bic)] 7: 475–477.
   Google Scholar
• Gutierrez J, Vergara MJ, Guerrero M, Fernandez O, Piedrola G, Morales P, Maroto MC (2002). Multiple sclerosis and human herpesvirus 6. Infection 30: 145–149.
   Google Scholar
• Hohlfeld R (1997). Biotechnological agents for the im-munotherapy of multiple sclerosis. Principles, problems and perspectives. Brain 120: 865–916.
   Google Scholar
• Hulshof S, Montagne L, De Groot CJ, Van Der Valk P (2002). Cellular localization and expression pat-terns of interleukin-10, interleukin-4, and their receptors in multiple sclerosis lesions. Glia 38: 24–35.
   Google Scholar
• Johnston JB, Silva C, Holden J, Warren KG, Clark AW, Power C (2001). Monocyte activation and differentiation aug-ment human endogenous retrovirus expression: impli-cations for inflammatory brain diseases. Ann Neurol 50: 434–442.
   Google Scholar
• Komurian-Pradel F, Paranhos-Baccala G, Bedin F, Ounanian-Paraz A, Sodoyer M, Ott C, Rajoharison A, Garcia E, Mallet F, Mandrand B, Perron H (1999). Molecular cloning and characterization of MSRV-related sequences associated with retrovirus-like particles. Virology 260: 1–9.
   Google Scholar
• Kwok S, Higuchi R (1989). Avoiding false positives with PCR. Nature 339: 237–238.
   Google Scholar
• Lafon M, Jouvin-Marche E, Marche PN, Perron H (2002). Human viral superantigens: to be or not to be transacti-vated? Trends Immunol 23: 238–239.
   Google Scholar
• Laman JD, Thompson EJ, Kappos L (1998). Balancing the Th1/Th2 concept in multiple sclerosis. Immunol Today 19: 489–490.
   Google Scholar
• Menard A, Amouri R, Michel M, Marcel F, Brouillet A, Belliveau J, Geny C, Deforges L, Malcus-Vocanson C, Armstrong M, Lyon-Caen O, Mandrand B, Dobransky T, Rieger F, Perron H (1997). Gliotoxicity, reverse transcriptase activity and retroviral RNA in mono-cyte/macrophage culture supernatants from patients with multiple sclerosis. FEBS Lett 413: 477–485.
   Google Scholar
• Miljkovic DJ, Drulovic J, Trajkovic V, Mesaros S, Dujmovic I, Maksimovic D, Samardzic T, Stojsavljevic N, Levic Z, Mostarica Stojkovic M (2002). Nitric oxide metabolites and interleukin-6 in cerebrospinal fluid from multiple sclerosis patients. Eur I Neurol 9: 413–418.
   Google Scholar
• Navikas V, Matusevicius D, Soderström M, Frederikson S, Kivisakk P, Ljungdahl A, Hojeberg B, Link H (1996). In-creased interleukin-6 mRNA expression in blood and cerebrospinal fluid mononuclear cells in multiple scle-rosis. I Neuroimmunol 64: 63–69.
   Google Scholar
• Noseworthy JH, Lucchinetti C, Rodriguez M, Weinhenker BG (2000). Multiple sclerosis. New Engl I Med 343: 938–962.
   Google Scholar
• Ochi H, Wu XM, Osoegawa M, Horiuchi I, Minohara M, Mural H, Ohyagi Y, Furuya H, Kira J (2001). Tc1/Tc2 and Th1/Th2 balance in Asian and Western types of multiple sclerosis (MS), HTLV-I-associated myelopa-thy/tropical spastic paraparesis (HAM/TSP) and hyper-IgEaemic myelitis. J Neuroimmunol 119: 297–305.
   Google Scholar
• Olsson T (1995). Critical influences of the cytokine or-chestration on the outcome of myelin antigen-specific T-cell autoimmunity in experimental autoimmune en-cephalomyelitis and multiple sclerosis. Immunol Rev 144: 245–268.
   Google Scholar
• Ozenci V, Kouwenhoven M, Link H (2002). Cytokines in multiple sclerosis: methodological aspects and pathogenic implications. Mult Scler 8: 396–404.
   Google Scholar
• Panitch HS (1994). Influence of infection on exacerbations of multiple sclerosis. Ann Neurol 36: S25–S28.
   Google Scholar
• Panitch HS, Hirsch RL, Schindler J, Johnson KP (1987). Treatment of multiple sclerosis with gamma interferon: exacerbations associated with activation of the immune system. Neurology 37: 1097–1029.
   Google Scholar
• Perron H, Garson JA, Bedin F, Beseme F, Paranhos-Baccala G, Komurian-Pradel F, Mallet F, Tuke PW, Voisset C, Blond JL, Lalande B, Seigneurin JM, Mandrand B(1997). Molecular identification of a novel retro-virus repeatedly isolated from patients with multi-ple sclerosis. Proc Natl Acad Sci U S A 94: 7583–7588.
   Google Scholar
• Perron H, Jouvin-Marche E, Michel M, Ounanian-Paraz A, Camelo S, Dumon A, Jolivet-Reynaud C, Marcel F, Souillet Y, Borel E, Gebuhrer L, Santoro L, Marcel S, Seigneurin JM, Marche PN, Lafon M (2001). Multiple sclerosis retrovirus particles and recombinant envelope trigger an abnormal immune response in vitro, by induc-ing polyclonal Vbeta16 T-lymphocyte activation. Virol-ogy 287: 321–332.
   Google Scholar
• Perron H, Perin JP, Rieger F, Alliel PM (2000). Particle-associated retroviral RNA and tandem RGH/HERV-W copies on human chromosome 7q: possible compo-nents of a 'chain-reaction' triggered by infectious agents in multiple sclerosis? J NeuroVirol 6 (Suppl 2): S67–S75.
   Google Scholar
• Pitha PM (1994). Multiple effects of interferon on the repli-cation of human immunodeficiency virus type 1. Antivi-ral Res 24: 205–219.
   Google Scholar
• Rosati G (2001). The prevalence of multiple sclerosis in the world: an update. Neurol Sci 22: 117–140.
   Google Scholar
• Rudge P (1991). Does a retrovirally encoded superantigen cause multiple sclerosis?J Neurol Neurosurg. Psychiatry 54: 853–855.
   Google Scholar
• Sotgiu S, Serra C, Mameli G, Pugliatti M, Rosati G, Arru G, Dolei A (2002). Multiple sclerosis (MS)-associated retro-virus and MS prognosis: an observational study. Neurol-ogy 59: 1071–1073.
   Google Scholar
• Steiner I, Nisipianu P, Wirguin I (2001). Infection and the etiology and pathogenesis of multiple sclerosis. Curr Neurol Neurosci Rep 1: 271–276.
   Google Scholar
• Tristem M (2000). Identification and characterization of novel human endogenous retrovirus families by phylo-genetic screening of the human genome mapping project database. J Virol 74: 3715–3730.
   Google Scholar
• Wang X, Chen M, Wandinger KP, Williams G, Dhib-Jalbut S(2000). IFN-beta-lb inhibits IL-12 production in pe-ripheral blood mononuclear cells in an IL-10-dependent mechanism: relevance to IFN-beta-lb therapeutic effects in multiple sclerosis. J Immunol 165: 548–557.
   Google Scholar
• Wilson CA, Wong S, Muller J, Davidson CE, Rose TM, Burd P(1998). Type C retrovirus released from porcine pri-mary peripheral blood mononuclear cells infects human cells. J Virol 72: 3082–3087.
   Google Scholar